United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Aug 31, 2026 · Filed Sep 1, 2026

On Aug 31, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$511.08 for US$4.86M under a trading plan, leaving 324,443 shares. Filed Sep 1, 2026 (Form 4).

Sold
9,500 shares
Price
US$511.08 average (US$507.84 to US$514.96)
Value
US$4.86M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 31, 2026Common StockOption exercise9,500US$135.42333,943Indirect
Aug 31, 2026Common StockSale599US$507.84333,344Indirect
Aug 31, 2026Common StockSale794US$508.92332,550Indirect
Aug 31, 2026Common StockSale810US$509.84331,740Indirect
Aug 31, 2026Common StockSale4,217US$510.93327,523Indirect
Aug 31, 2026Common StockSale1,600US$511.75325,923Indirect
Aug 31, 2026Common StockSale678US$513.50325,245Indirect
Aug 31, 2026Common StockSale762US$514.32324,483Indirect
Aug 31, 2026Common StockSale40US$514.96324,443Indirect

Source

View original at SEC

Related